The federal government has negotiated a series of agreements with major pharmaceutical companies to offer certain drugs at dramatically reduced prices to U.S. consumers. Part of the deal involves direct-to-consumer sales through TrumpRx.gov. However, direct-to-consumer sales may not work for everyone.

“These programs will be most beneficial for those who are uninsured or who may not have coverage of a particular medication through their benefits,” said our own Shanda Harclerode, Holmes Murphy Pharmacist and Pharmacy Consultant.

What else do you need to know? Click here to read the full article in The Epoch Times.